Mouse SR-AI/MSR Antibody
R&D Systems, part of Bio-Techne | Catalog # AF1797
Scientific images may be resized, cropped, or adjusted for brightness or contrast for presentation purposes. These updates are limited to presentation and do not affect the underlying scientific interpretation of the data. Where available, additional source data may be provided upon request.
Key Product Details
Species Reactivity
Validated:
Cited:
Applications
Validated:
Cited:
Label
Antibody Source
Product Specifications
Immunogen
Trp79-Ser454
Accession # AAA39747
Specificity
Clonality
Host
Isotype
Endotoxin Level
Scientific Data Images for Mouse SR-AI/MSR Antibody
Detection of Mouse SR-AI/MSR by Western Blot
CKIP-1 diminishes Oct-1-mediated LOX-1 expression. e Expression of LOX-1, CD36, and SR-A in Ckip-1−/− and Ckip-1−/−R BMDMs. Image collected and cropped by CiteAb from the following open publication (https://pubmed.ncbi.nlm.nih.gov/30683852), licensed under a CC-BY license. Not internally tested by R&D Systems.Detection of Mouse SR-AI/MSR by Western Blot
CKIP-1 diminishes Oct-1-mediated LOX-1 expression. c Expression of LOX-1, CD36, and SR-A in WT and Ckip-1−/− BMDMs after 24 h incubation with or without 20 μg per ml oxLDL. Image collected and cropped by CiteAb from the following open publication (https://pubmed.ncbi.nlm.nih.gov/30683852), licensed under a CC-BY license. Not internally tested by R&D Systems.Detection of SR-AI/MSR by Western Blot
Effects of kcnq1ot1 on cholesterol transporter and receptor expression. A, B The mRNA and protein levels of ABCA1, ABCG1, CD36, and SR-A in the aorta from apoE−/− mice were assayed by qRT-PCR and western blot, respectively (n = 10). C, D qRT-PCR and western blot analyses of ABCA1, ABCG1, CD36 and SR-A expression in MPMs from apoE−/− mice (n = 5). E, F After treatment of THP-1 macrophages with PBS, LV-NC or LV-kcnq1ot1 for 72 h, both qRT-PCR and western blot were employed for detection of ABCA1, ABCG1, CD36, and SR-A expressions. Data are represented as mean ± SD. ***P < 0.001; ns not significant. Image collected and cropped by CiteAb from the following open publication (https://pubmed.ncbi.nlm.nih.gov/33293505), licensed under a CC-BY license. Not internally tested by R&D Systems.Applications for Mouse SR-AI/MSR Antibody
Blockade of Receptor-ligand Interaction
Western Blot
Sample: Recombinant Mouse SR-AI/MSR (Catalog # 1797-MS)
Formulation, Preparation, and Storage
Purification
Reconstitution
Formulation
Shipping
Stability & Storage
- 12 months from date of receipt, -20 to -70 °C as supplied.
- 1 month, 2 to 8 °C under sterile conditions after reconstitution.
- 6 months, -20 to -70 °C under sterile conditions after reconstitution.
Background: SR-AI/MSR
The scavenger receptor (SR) family comprises a group of functionally defined membrane receptors that share the common ability to bind and internalize modified forms of Low Density Lipoproteins (mLDL) (1 - 3). Family members are classified alphabetically. The A class include four proteins: the three subtypes of SR-A (AI, AII, and AIII) that are generated by alternative splicing of the same gene, and a structurally similar protein named MARCO (4). All A class SRs are multidomain trimeric type II membrane proteins. SR-AI has an N-terminal cytoplasmic domain, a transmembrane domain, a spacer domain, an alpha-helical coiled coil, a collagen-like domain and a C-terminal cysteine-rich domain. SR-A is expressed by most tissue macrophages, dendritic cells and Kupffer cells. It is also highly expressed by microglia in neonatal as well as Alzheimer’ Disease brains. SR-AI binds a broad range of polyanionic ligands including modified proteins (e.g. Oxidized, acetylated or maleylated LDL, Advanced glycation end-product proteins), polyribonucleotides (polyguanosine and polyinosine), polysaccharides (dextran sulfate, fucoidan), phospholipids (phosphatidylserine), bacterial products (lipopolysaccharide and lipoteichoic acid) and selected chemical compounds (silica, crocidolite asbestos). The ligand-binding region has been localized to a positively charged region in the carboxyl end of the collagen-like domain. Based on its ligand binding characteristics, SR-AI is implicated in many physiological and pathophysiological functions. Studies using SR-A knockout mouse have also suggested roles of SR-A in atherogenesis, host defense and innate immunity, acquired immune responses, macrophage adhesion, and phagocytosis of apoptotic cells (1 - 3).
References
- Daugherty, A. et al. (2000) Curr. Opin. Cardiovasc. Pulm. Ren. Invest. Drugs 2:223.
- Platt, N. and S. Gordon (2001) J. Clin. Invest. 108:649.
- Platt, N. and S. Gordon (1998) Chem. Biol. 5:R193.
- Elomaa, O. et al. (1995) Cell 80:603.
Long Name
Alternate Names
Gene Symbol
UniProt
Additional SR-AI/MSR Products
Product Documents for Mouse SR-AI/MSR Antibody
Product Specific Notices for Mouse SR-AI/MSR Antibody
For research use only